NextCure, Inc. - Common Stock (NXTC)
Historical Holders from Q2 2019 to Q3 2025
-
Type / Class
-
Equity / Common Stock
-
Symbol
-
NXTC on Nasdaq
-
Shares outstanding
-
28,027,744
-
Price per share
-
$5.86
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
21,833
-
Total reported value
-
$127,941
-
% of total 13F portfolios
-
0%
-
Share change
-
-10,523,357
-
Value change
-
-$6,933,766
-
Number of holders
-
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of NextCure, Inc. - Common Stock (NXTC) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
CITIGROUP INC
|
4.3%
|
|
$506,181
|
|
1,205,193
|
|
Citigroup Global Markets Inc.
|
31 Mar 2025
|
As of 30 Sep 2025,
NextCure, Inc. - Common Stock (NXTC) has
1
institutional shareholder
filing 13F forms.
They hold
21,833 shares.
of 28,027,744
outstanding shares (0.08%)
.
Institutional Holders of NextCure, Inc. - Common Stock (NXTC) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
21,833
|
$127,941
|
-$6,933,766
|
|
|
$5.86
|
1
|
|
2025 Q2
|
10,545,575
|
$5,647,089
|
-$11,042,788
|
|
$0
|
$0.46
|
29
|
|
2025 Q1
|
15,365,612
|
$7,377,835
|
-$659,368
|
|
$817
|
$0.48
|
38
|
|
2024 Q4
|
14,576,884
|
$11,238,169
|
-$3,082,628
|
|
|
$0.77
|
45
|
|
2024 Q3
|
15,865,008
|
$21,732,882
|
-$163,706
|
|
$0
|
$1.37
|
44
|
|
2024 Q2
|
16,009,076
|
$25,452,390
|
-$417,831
|
|
$2,226
|
$1.59
|
47
|
|
2024 Q1
|
16,144,047
|
$35,999,098
|
+$6,299,292
|
|
$23,415
|
$2.23
|
46
|
|
2023 Q4
|
13,341,936
|
$15,275,154
|
-$369,923
|
|
$228
|
$1.14
|
42
|
|
2023 Q3
|
12,895,574
|
$16,633,500
|
-$700,863
|
|
$36,636
|
$1.29
|
39
|
|
2023 Q2
|
13,318,875
|
$23,971,765
|
+$169,807
|
|
$87,480
|
$1.80
|
42
|
|
2023 Q1
|
13,265,273
|
$19,631,094
|
-$159,489
|
|
$92,352
|
$1.48
|
42
|
|
2022 Q4
|
13,389,531
|
$18,876,133
|
-$5,000,007
|
$0
|
$86,574
|
$1.41
|
44
|
|
2022 Q3
|
15,242,782
|
$41,759,784
|
+$1,686,368
|
$226,000
|
$65,000
|
$2.75
|
48
|
|
2022 Q2
|
14,456,827
|
$67,938,572
|
+$5,637,581
|
$369,000
|
$1,087,000
|
$4.70
|
49
|
|
2022 Q1
|
13,233,257
|
$64,321,105
|
-$6,638,844
|
$258,000
|
$217,000
|
$4.86
|
57
|
|
2021 Q4
|
14,366,664
|
$86,200,310
|
-$4,439,158
|
$255,000
|
$494,000
|
$6.00
|
68
|
|
2021 Q3
|
14,744,107
|
$99,459,595
|
-$5,380,167
|
$290,000
|
$537,000
|
$6.74
|
66
|
|
2021 Q2
|
15,461,583
|
$124,156,911
|
-$24,114,984
|
$972,000
|
$1,626,000
|
$8.03
|
74
|
|
2021 Q1
|
17,959,308
|
$179,779,328
|
+$33,903,656
|
$2,948,000
|
$1,035,000
|
$10.01
|
91
|
|
2020 Q4
|
14,545,518
|
$158,547,717
|
-$35,131,387
|
$1,366,000
|
$1,756,000
|
$10.90
|
80
|
|
2020 Q3
|
18,265,185
|
$160,694,375
|
-$76,990,689
|
$626,000
|
$1,229,000
|
$8.80
|
73
|
|
2020 Q2
|
20,244,521
|
$434,046,210
|
-$4,189,870
|
$959,000
|
$322,000
|
$21.44
|
87
|
|
2020 Q1
|
20,204,298
|
$748,968,161
|
-$2,574,956
|
$2,176,000
|
$0
|
$37.07
|
81
|
|
2019 Q4
|
20,192,753
|
$1,137,417,349
|
+$381,121,391
|
$1,138,000
|
$439,000
|
$56.33
|
88
|
|
2019 Q3
|
11,288,924
|
$348,260,350
|
+$50,213,398
|
|
|
$30.85
|
52
|
|
2019 Q2
|
10,754,678
|
$161,093,210
|
+$161,093,000
|
|
|
$14.98
|
42
|